Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension
NCT02169752
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class
Stopped
PI left National Jewish Health
Conditions
Pre-Pulmonary Atrial Hypertension
Interventions
DRUG:
Ambrisentan
Sponsor
National Jewish Health